Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Anaplastic thyroid carcinoma (ATC) is almost universally fatal. Elevated keratin-8 (KRT8) protein expression is an established diagnostic cancer biomarker in several epithelial cancers (but not ATC). Several keratins, including KRT8, have been suggested to have a role in cell biology beyond that of structural cytoskeletal proteins. Here, we provide evidence that KRT8 plays a direct role in the growth of ATCs. Genomic and transcriptomic analysis of >5000 patients demonstrates that mutation and copy number amplification are frequently evident in epithelial-derived cancers. Carcinomas arising from diverse tissues exhibit mRNA and protein overexpression when compared to normal tissue levels. Similarly, in a panel of patient-derived ATC cell lines and patient tumors, KRT8 expression shows a similar pattern. sh-RNA-mediated knockdown in these cell lines increases apoptosis, whereas forced overexpression of KRT8 confers resistance to apoptosis under peroxide-induced cell stress conditions. We further show that KRT8 protein binds to annexin A2, a protein known to mediate apoptosis as well as the redox pathway.
Li J, Yu K, Chen D, Luo G, Jia J Clinics (Sao Paulo). 2024; 79:100486.
PMID: 39277981 PMC: 11419804. DOI: 10.1016/j.clinsp.2024.100486.
The actin cytoskeleton: Morphological changes in pre- and fully developed lung cancer.
Basu A, Paul M, Weiss S Biophys Rev (Melville). 2024; 3(4):041304.
PMID: 38505516 PMC: 10903407. DOI: 10.1063/5.0096188.
Wang C, Shih S, Chen K, Huang P Biomedicines. 2023; 11(1).
PMID: 36672532 PMC: 9856081. DOI: 10.3390/biomedicines11010024.
Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes.
Gao T, Soldatov R, Sarkar H, Kurkiewicz A, Biederstedt E, Loh P Nat Biotechnol. 2022; 41(3):417-426.
PMID: 36163550 PMC: 10289836. DOI: 10.1038/s41587-022-01468-y.
Mackay R, Weinberger P, Copland J, Mahdavian E, Xu Q Mol Cancer Ther. 2022; 21(6):925-935.
PMID: 35405742 PMC: 9167740. DOI: 10.1158/1535-7163.MCT-21-0619.